News from eli lilly and company A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 06, 2015, 08:00 ET
Eli Lilly and Company logo.

Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts

Eli Lilly and Company (NYSE: LLY) today announced plans to establish a new drug delivery and device innovation center in Cambridge, Massachusetts...

May 04, 2015, 14:26 ET
Eli Lilly and Company logo.

Lilly Declares Second-Quarter 2015 Dividend

 The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2015 of $0.50 per share on...

May 04, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly Releases Corporate Responsibility, Global Health Reports

Eli Lilly and Company (NYSE: LLY) today released two new reports that provide a comprehensive overview of the company's corporate...

May 01, 2015, 13:05 ET
Eli Lilly and Company logo.

Lilly to Participate in Bank of America Merrill Lynch Health Care Conference

Eli Lilly and Company (NYSE: LLY) will attend the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13, 2015. Derica...

Apr 28, 2015, 07:00 ET
Eli Lilly and Company logo.

Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed

 People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent are prescribed an oral antiplatelet...

Apr 24, 2015, 16:27 ET
Eli Lilly and Company logo.

Lilly's CYRAMZA® (ramucirumab) Receives Fourth FDA Approval

Eli Lilly and Company (NYSE: LLY) has received its fourth U.S. Food and Drug Administration (FDA) approval for CYRAMZA®...

Apr 23, 2015, 06:25 ET
Eli Lilly and Company logo

Lilly Reports First-Quarter 2015 Results

- Revenue declined 1 percent due to the unfavorable impact of foreign exchange rates and the continuing impact of Cymbalta and Evista...

Apr 20, 2015, 09:00 ET
Eli Lilly and Company logo

Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015

 Eli Lilly and Company (NYSE: LLY) will present early stage data from several targeted cancer therapies, reflecting Lilly's diverse oncology...

Apr 20, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis

Eli Lilly and Company (NYSE: LLY) announced today that the investigational medicine ixekizumab was statistically superior to placebo in the...

Apr 01, 2015, 13:00 ET
Eli Lilly and Company logo.

Lilly Confirms Date and Conference Call for First-Quarter 2015 Financial Results Announcement

Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2015 on Thursday, April 23, 2015.  Lilly will...

Mar 30, 2015, 13:00 ET
Eli Lilly and Company logo

Preparation Is Personal for Those with Chronic Illnesses

News Highlights: - .@TheAACE and @LillyDiabetes highlight the My Diabetes Emergency Plan at the 2015 @NatHurricaneCon - .@TheAACE and...

Mar 30, 2015, 10:00 ET
Eli Lilly and Company logo.

Lilly Announces Date for Diabetes Investor Meeting

Eli Lilly and Company (NYSE: LLY) will conduct a meeting on June 7 to update the investment community and media on the company's diabetes business....

Mar 23, 2015, 08:30 ET
Eli Lilly and Company logo

First-in-class type 2 diabetes treatment Glyxambi® (empagliflozin/linagliptin) tablets for adults now available in U.S. pharmacies

 Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across...

Mar 20, 2015, 08:00 ET
Eli Lilly and Company logo

Lilly and Innovent Biologics Announce a Strategic Alliance to Bring Potential Oncology Therapies to Patients in China and Around the World

 Eli Lilly and Company (NYSE:LLY) and Innovent Biologics, Inc. (Innovent) today announced one of the largest biotech drug development...

Mar 19, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly and Hanmi Announce an Exclusive License and Collaboration Agreement for the Development and Commercialization of an Immunological Therapy

 Eli Lilly and Company (NYSE: LLY) and Hanmi Pharmaceutical Co., Ltd. (Hanmi) today announced they have entered into an exclusive license and...

Mar 06, 2015, 08:30 ET
Eli Lilly and Company logo

German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit

 The German Court of Appeal has ruled that Eli Lilly and Company's (NYSE: LLY) vitamin regimen patent for Alimta® (pemetrexed disodium)...

Mar 04, 2015, 09:00 ET
Eli Lilly and Company logo

Lilly and IU School of Medicine Partner on Rotation Program for Medical Students

 Students from Indiana University School of Medicine are getting a first-hand look at how new medicines are discovered. Through a partnership...

Mar 03, 2015, 14:30 ET
Eli Lilly and Company logo.

Lilly to Participate in Barclays Global Healthcare Conference

Eli Lilly and Company (NYSE: LLY) will attend the Barclays Global Healthcare Conference on Wednesday, March 11, 2015. Jan M. Lundberg, Ph.D.,...

Feb 24, 2015, 14:00 ET
Eli Lilly and Company logo.

Lilly to Present at Cowen Health Care Conference

Eli Lilly and Company (NYSE: LLY) will present at the 35th Annual Cowen and Company Health Care Conference on Tuesday, March 3, 2015. Mr. David...

Feb 23, 2015, 08:30 ET
Eli Lilly and Company logo.

Lilly Announces Update on Regulatory Submission Timing for Basal Insulin Peglispro

 Eli Lilly and Company (NYSE: LLY) today announced a delay in the submission of basal insulin peglispro (BIL) to regulatory agencies beyond the...